询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
Tetramethylphosphonium iodide | CAS:993-11-3
Tetramethylphosphonium iodide
  • 名称:四甲基碘化膦 | Tetramethylphosphonium iodide
  • CAS号:993-11-3
  • 别名:NSC 617058
  • 分子式:C4H12P.I
  • 分子量:218.02
  • EINESC号:213-605-1

产品描述

物理化学性质

熔点 312-322 ºC (dec.)

安全数据

没有数据没有数据

SDS

来源 SDS样本
Alfa-Aesar 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
[Hypercalcemia].U K Naumann et al.Praxis, 92(38), 1567-1571 (2003-12-06) Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol.J M Boots et al.The Netherlands journal of medicine, 54(1), 16-20 (1999-02-27) 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells.Bhaskar S Mandavilli et al.Brain research. Molecular brain research, 133(2), 215-223 (2005-02-16) Is there a relationship between Helicobacter pylori and gastric autoimmunity?Aşkın Erdoğan et al.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 22(2), 134-138 (2011-07-29) Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol.D R Jehle et al.Journal of medicine, 30(1-2), 39-50 (1999-10-09) The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.A L Voigts et al.Archives of internal medicine, 143(5), 960-963 (1983-05-01) Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).S L Fan et al.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 15(12), 1943-1949 (2000-11-30) Gas chromatographic studies of vitamins D2 and D3Nair PP, et al. Analytical Chemistry, 37(6), 631-636 (1965) [Treatment of hypoparathyroidism].Emma Varga Orvosi hetilap, 146(20), 1019-1020 (2005-06-11) Effects of new analogues of vitamin D on bone cells: implications for treatment of uremic bone disease.C W McIntyre et al.Kidney international, 55(2), 500-511 (1999-02-13) 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.R H Mak Kidney international, 53(5), 1353-1357 (1998-05-09) Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.Neil J Schroeder et al.Nephron. Physiology, 94(4), p62-p73 (2003-09-16) Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients.Nirav Shah et al.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 25(4), 362-366 (2005-07-19) Protection by vitamin D against high-glucose-induced damage in retinal pigment epithelial cells.Ali Mohammad Tohari et al.Experimental cell research, 392(1), 112023-112023 (2020-04-24) 1, 25 (OH) 2D levels in dihydrotachysterol-treated patients: Influence on 1, 25 (OH) 2D assaysTaylor A and Norman ME Journal of Bone and Mineral Research, 2(6), 567-570 (1987) Current therapy of hypoparathyroidism--a survey of German endocrinology centers.T Schilling et al.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 105(4), 237-241 (1997-01-01) Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide-delivery model of polyglutamine-induced neuronal death.Mari Suzuki et al.Journal of neuroscience research, 80(4), 549-561 (2005-04-13) Calpain-mediated AQP2 proteolysis in inner medullary collecting duct.Dechu P Puliyanda et al.Biochemical and biophysical research communications, 303(1), 52-58 (2003-03-21) Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats.J H Earm et al.Journal of the American Society of Nephrology : JASN, 9(12), 2181-2193 (1998-12-16) Tumor necrosis factor-alpha induces renal cyclooxygenase-2 expression in response to hypercalcemia.Sailaja Battula et al.Prostaglandins & other lipid mediators, 99(1-2), 45-50 (2012-07-18) 1,25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappaB.Jihwa Chung et al.Laboratory investigation; a journal of technical methods and pathology, 87(6), 540-547 (2007-04-03) Neurotensin-induced Cl(-) current in guinea-pig dorsal root ganglion cells.S Kawarada et al.European journal of pharmacology, 404(1-2), 69-78 (2000-09-12) Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation.Y-F Lin et al.Neuroscience, 152(2), 371-380 (2008-02-19) Serum dihydrotachysterol levels and biological action in normal manTAYLOR A, et al. The Journal of clinical endocrinology and metabolism, 67(1), 198-202 (1988) Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.I Quack et al.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 113(7), 376-380 (2005-07-19) Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors.H Mangat et al.The Journal of clinical investigation, 100(8), 1941-1950 (1997-10-23) [Cerebral calcinosis].J G Heckmann et al.Medizinische Klinik (Munich, Germany : 1983), 96(1), 55-56 (2001-02-24) Coefficients for active transport and thermogenesis of Ca2+-ATPase isoforms.Signe Kjelstrup et al.Biophysical journal, 96(11), 4376-4386 (2009-06-03) Suspected pseudohypoparathyroidism in a domestic ferret.G Heather Wilson et al.Journal of the American Veterinary Medical Association, 222(8), 1093-1096 (2003-04-25) In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha, 25-and 1 beta, 25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity.Qaw F, et al. Test, 268(1), 282-292 (1993)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交